¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"time compensation curve"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • probability curve
    È®·ü°î¼±
  • pulse curve
    ¸Æ¹Ú°î¼±
  • percentage depth dose curve
    ½ÉºÎ¼±·®¹éºÐÀ²°î¼±
  • phase curve
    À§»ó°î¼±
  • quadratic curve
    ÀÌÂ÷°î¼±
  • receiver operating characteristic curve
    ¼ö½Å±âÀÛµ¿Æ¯¼º°î¼±
  • regression curve
    ȸ±Í°î¼±
  • response curve
    ¹ÝÀÀ°î¼±
  • solubility curve
    ¿ëÇØµµ°î¼±
  • stiffness curve
    °æÁ÷µµ°î¼±, °­Á÷µµ°î¼±
  • strength duration curve
    °­µµ±â°£°î¼±
  • survival curve
    »ýÁ¸°î¼±
  • sensitometric curve
    °¨±¤µµ°è°î¼±
  • shadow curve
    À½¿µ°î¼±
  • sigmoid dose-response curve
    ±¸ºÒ¼±·®¹ÝÀÀ°î¼±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • plane curve
    Æò¸é°î¼±
  • polar curve
    ±ØÁÂÇ¥°î¼±
  • preponderance curve
    ¿ì¼¼°î¼±
  • pressure volume curve
    ¾Ð·Â¿ëÀû°î¼±
  • probability curve
    È®·ü°î¼±
  • pulse curve
    ¸Æ¹Ú°î¼±
  • quadratic curve
    ÀÌÂ÷°î¼±
  • receiver operating characteristic curve
    ¼ö½Å±âÀÛµ¿Æ¯¼º°î¼±
  • regression curve
    ȸ±Í°î¼±
  • response curve
    ¹ÝÀÀ°î¼±
  • sensitometric curve
    °¨±¤µµ°è°î¼±
  • shadow curve
    À½¿µ°î¼±
  • sigmoid dose-response curve
    ±¸ºÒ¼±·®¹ÝÀÀ°î¼±
  • single-step growth curve
    ÀÏȸÁõ½Ä°î¼±
  • solubility curve
    ¿ëÇØµµ°î¼±
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • persistence time
    Áö¼Ó½Ã°£(ò¥áÙãÁÊà).
  • phonation time
    ¹ß¼ºÁö¼Ó½Ã°£
  • plasma prothrombin time
    Ç÷ÀåÇÁ·ÎÆ®·Òºó ½Ã°£.
  • polymerizing time
    ±»´Â ½Ã°£ (ÁßÇÕ ½Ã°£)
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£.
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó ½Ã°£
  • prothromhin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • pulmonary circulation time
    Æó¼øÈ¯½Ã°£(¡­ãÁÊà).
  • reaction time
    ¹ÝÀÀ½Ã(°£)(ÚãëëãÁÊà).
  • real time
    ½Ç½Ã°£, Áï½Ã.
  • real time
    ½Ç½Ã°£
  • real time acquisition
    ½Ç½Ã°£ ȹµæ
  • real time display
    ½Ç½Ã°£ Ç¥½Ã
  • real time image
    ½Ç½Ã°£ ¿µ»ó
  • real time imaging
    ½Ç½Ã°£ ¿µ»ó ±â¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • curve, single-step growth
    ÀÏȸÁõ½Ä°î¼±
  • demand curve
    ¼ö¿ä°î¼±(ËàËíË­ËÛ).
  • depth dose curve
    ½ÉºÎ¼±·®°î¼±
  • dissociation curve
    ÇØ¸®°î¼±(ú°ìÆÍØàÊ).
  • distribution curve
    ºÐÆ÷°î¼±(ÊÙË­ËÛ).
  • dose response curve
    ¹æ»ç [¾à¸®,º´¸®,»ýÈ­,ÇÙÀÇ]¿ë·®¹ÝÀÀ°î¼±(éÄåÖÚãëëÍØàÊ).
  • dose response curve
    ¹æ»ç ¾à¸®,º´¸®,»ýÈ­,ÇÙÀǿ뷮´ëÀÀ°î¼±(éÄåÖÓßëëÍØàÊ).
  • dose response curve/relationship
    ¿ë·®-¹ÝÀÀ°î¼±/°ü°è.
  • dose-response curve
    ¼±·®¹ÝÀÀ°î¼±
  • dose-response curve
    ¿ë·®¹ÝÀÀ°î¼±(éÄÕáÚãëëÍØàÊ)
  • dye dilution curve
    »ö¼ÒÈñ¼®°î¼±(ßäáÈýüà·ÍØàÊ).
  • elastic curve
    ź¼º°î¼±(÷¥àõÍØàÊ).
  • electrocardiographic curve
    ½ÉÀüµµ°î¼±.
  • epidemic curve
    À¯Çິ(Àü¿°º´)°î¼±
  • epidemic curve
    À¯Çà°î¼±.
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • time of flight MR angiography
    À¯Ã¼¼Óµµ°­Á¶ ÀÚ±â°ø¸íÇ÷°üÁ¶¿µ¼ú
  • time of flight phenomenon
    À¯Ã¼¼Óµµ°­Á¶Çö»ó
  • time sharing
    ½Ã°£°øÀ¯, ½ÃºÐÇÒ
  • time velocity integral
    ½Ã°£¼ÓµµÁ¤¼ö
  • TM scan(Time motion)
    ½Ã°£¿îµ¿¹æ½Ä
  • TOF [=time of flight]
    È帧½Ã°£, TOF, À¯Ã¼ ¼Óµµ °­Á¶
  • transit time
    ÀüÀ̽ð£
  • transverse relaxation time
    ȾÃàÀ̿Ͻð£
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
MICRA Medical Injury Compensation Reform Act
NCS National Collaborative Study; neocarcinostatin; nerve conduction study; newborn calf serum; no conce...
RC an electronic circuit containing a resistor and capacitor in series; radiocarpal; reaction center; r...
RCE reasonable compensation equivalent
TC target cell; taurocholate; temperature compensation; teratocarcinoma; tertiary cleavage; tetracyclin...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
ROC Receiver Operator Curve
TC Tuning curve
AUIC are under the inhibitory curve
C max curve , maximum plasma concentration
FTC frequency threshold curve
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hardening time
    °æÈ­ ½Ã°£
    Ä¡°ú¿ë ÀλóÀç ¶Ç´Â ¼®°í°¡ µüµüÇÏ°Ô ±»´Âµ¥ °É¸®´Â ½Ã°£.
  • heating and cooling temperature-place-time profile
    °¡¿­ ¹× ³Ã°¢ ¿Âµµ-À§Ä¡-½Ã°£ Çü
  • inversion time
    ¿ªÀü ½Ã°£
  • left ventricular ejection time
    Á ½É½Ç ±¸Ç÷ ±â°£
  • mixing time
    ±³¹Ý ½Ã°£, È¥ÇÕ ½Ã°£
    µÎ °¡Áö ÀÌ»óÀÇ Àç·á¸¦ È¥ÇÕÇÒ ¶§ ¼Ò¿äµÇ°Å³ª ÁöÄÑ¾ß ÇÏ´Â ½Ã°£À¸·Î, Ä¡°ú ¿µ¿ª¿¡¼­´Â ¼®°í Àç·á, ½Ã¸àÆ®, ¼öÁö, ÀλóÀç, ¸Å¸ôÀç µî¿¡¼­ ÁؼöµÇ¾î¾ß ÇÒ ½Ã°£. Àç·áÀÇ ¹°¸®Àû ¼ºÁú¿¡ ¿µÇâÀ» ÁØ´Ù.
  • operative time
    ¼ö¼ú ½Ã°£
  • partial prothrombin time
    ºÎºÐ ÇÁ·ÎÆ®·Òºó ½Ã°£
  • persistence time
    Áö¼Ó ½Ã°£
  • plasma prothrombin time
    Ç÷Àå ÇÁ·ÎÆ®·Òºó ½Ã°£
  • prolonged bleeding time
    ¿¬ÀåµÈ ÃâÇ÷ ½Ã°£
  • real time acquisition
    ½Ç½Ã°£ ȹµæ
  • real time image
    ½Ç½Ã°£ ¿µ»ó
  • real time study
    ½Ç½Ã°£ °Ë»ç
  • relaxation time
    ÀÌ¿Ï ½Ã°£
  • retention time
    ÀÜ·ù ½Ã°£
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
flow-volume curve The graph produced by plotting the instantaneous flow of respiratory gas against the simultaneous lung volume, usually during maximal forced expiration.
(05 Mar 2000)
force-velocity curve The relationship between isotonic velocity of shortening and afterload for a contracting muscle.
(05 Mar 2000)
Frank-Starling curve A graph in which cardiac output or stroke volume is plotted against mean atrial or ventricular end-diastolic pressure; with increasing venous return and atrial pressure the output proportionately increases until further increments overload the heart and the output falls.
Synonym: Frank-Starling curve.
(05 Mar 2000)
frequency curve A systematic grouping of data into classes or categories according to the frequency of occurrence of each successive value or ranges of such values, resulting in a graph of a frequency distribution.
Synonym: frequency curve.
(05 Mar 2000)
Friedman curve A graph on which hours of labour are plotted against cervical dilation in centimeters.
(05 Mar 2000)
logistic curve An S-shaped curve which depicts the growth of a population in an area of fixed limits.
(05 Mar 2000)
activated clotting time The most common test used for coagulation time in cardiovascular surgery.
(05 Mar 2000)
activated partial thromboplastin time The time needed for plasma to form a fibrin clot following the addition of calcium and a phospholipid reagent; used to evaluate the intrinsic clotting system.
(05 Mar 2000)
A-H conduction time Forward conduction of the cardiac impulse from atria to ventricles via the A-V node or any bypass tract, represented in the electrocardiogram by the P-R interval. P-H conduction time is from the onset of the P wave to the first high frequency component of the His bundle electrogram (normally 119 ± 38 msec); A-H conduction time is from the onset of the first high frequency component of the atrial electrogram to the first high frequency component of the His bundle electrogram (normally 92 ± 38 msec); P-A conduction time is from the onset of the P wave to the onset of the atrial electrogram (normally 27 ± 18 msec).
(05 Mar 2000)
association time Time elasping between a stimulus and the verbalised response to it.
(05 Mar 2000)
biologic time The concept that our appreciation of time varies with age and is governed by the neural organization of the individual; it obeys a logarithmic rather than an arithmetic law.
(05 Mar 2000)
bleeding time <haematology> A test which measures the time it takes for small blood vessels to close off and bleeding to stop. Abnormal results can be seen in those with congenital or acquired platelet function disorders or thrombocytopenia.
(27 Sep 1997)
blood circulation time Determination of the shortest time interval between the injection of a substance in the vein and its arrival at some distant site in sufficient concentration to produce a recognizable end result. It represents approximately the inverse of the average velocity of blood flow between two points.
(12 Dec 1998)
P-A conduction time See: atrioventricular conduction.
(05 Mar 2000)
generation time <cell biology> Time taken for a cell population to double in numbers and thus equivalent to the average length of the cell cycle.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • cycle time
    »çÀÌŬ ŸÀÓ(±â¾ï ÀåÄ¡ÀÇ Àд ¼Óµµ)
  • dead time
    (ÀüÀÚ)ºÎµ¿½Ã°£;ºÒ°¨ ½Ã°£(Áö·ÉÈÄ ÀÛµ¿Çϱâ±îÁöÀÇ)
  • delayed time system
    (ÀüÀÚ)½Ã°£ Áö¿¬(ÃàÀû)¹æ½Ä
  • dinner time
    Á¤Âù ½Ã°¢
  • double time
    ±¸º¸
  • drinkingup time
    ¸¶Áö¸·ÀÜ ½Ã°£(ÆóÁ¡ ÈÄÀÇ ÂªÀº ¿µ¾÷ ¿¬Àå ½Ã°£)
  • duple time
    (¾Ç)2¹ÚÀÚ;(¹Ì)¦¼ö ¹ÚÀÚ
  • earth time
    Áö±¸½Ã(°£)(õü Çö»óÀ» Áö±¸»ó¿¡¼­ °üÃøÇÏ´Â µ¥ »ç¿ë,Áö±¸ ÀÚÀüÀÇ ½Ã°£ÀÌ ±âÁØÀÌ µÊ)
  • elapsed time
    °æ°ú ½Ã°£(ŸÀÓ)(º¸Æ®³ª ÀÚµ¿Â÷ÀÇ ÀÏÁ¤ ÄÚ½ºÀÇ ÁÖÇà ½Ã°£)
  • equal time
    (Á¤°ß ¹ßÇ¥¿¡¼­)ÆòµîÇÑ ¹æ¼Û½Ã°£ ÇÒ´ç;ÆòµîÇÑ ¹ß¾ð ±âȸ
  • extra time
    (½ºÆ÷Ã÷)(·Î½º ŸÀÓÀ» º¸ÃæÇϱâ À§ÇÑ)¿¬Àå ½Ã°£
  • fast time
    =daylight-saving time
  • flat time sentence
    Á¤±â ±Ý°íÇü
  • fringe time
    °í½Ãû·ü Àü¤¾¿ìÀÇ ½Ã°£´ë
  • full time
    (ÀÛ¾÷,±Ù¹«»óÀÇ Á¤±ÔÀÇ) Àü½Ã°£;(±¸±â µî¿¡¼­)¼ÒÁ¤ÀÇ ½ÃÇÕ ½Ã°£ ÀüºÎ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á